Acadia Healthcare ACHC
$34.60 +$0.13 (+0.38%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $34.60 0.00%
Open$33.91
Prev close$34.47
Day range$33.80 – $35.15
Volume1.92M
Market cap$3.22B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$895.31M+5.1% YoY
Operating profit$114.07M-4.6% YoY
Net profit$38.65M+0.9% YoY
Diluted EPS$0.38-5.0% YoY
Free cash flow$47.14M+174.8% YoY
Operating cash flow$97.88M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin96.4%
Operating margin9.8%
Net margin-33.1%
Return on equity-43.9%
Return on assets-18.9%
Return on invested capital-20.6%
Current ratio1.60
Liabilities / assets59.5%
Cash & investments$163.31M
Total debt$2.48B
Net cash (debt)-$2.32B
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $895.31M | $865.84M | $828.80M | $3.31B | $821.46M |
| Total Operating Revenue | $895.31M | $865.84M | $828.80M | $3.31B | $821.46M |
| Cost of Revenue | $31.50M | $30.20M | $29.49M | $118.05M | $30.76M |
| Gross Profit | $863.81M | $835.64M | $799.31M | $3.19B | $790.70M |
| Operating Expense | $749.74M | $747.87M | $715.48M | $2.81B | $743.05M |
| Selling and Admin Expenses | $560.86M | $541.70M | $531.97M | $2.06B | $521.20M |
| -General & Admin Expense | $560.86M | $541.70M | $531.97M | $2.06B | $521.20M |
| Depreciation & Amortization & Depletion | $53.13M | $50.43M | $52.43M | $189.25M | $45.75M |
| -Depreciation & Amortization | $53.13M | $50.43M | $52.43M | $189.25M | $45.75M |
| Other Operating Expenses | $135.74M | $155.75M | $131.08M | $553.31M | $176.11M |
| Operating Profit | $114.07M | $87.77M | $83.84M | $387.97M | $47.64M |
| Net Non-Operating Interest Income (Expense) | -$37.28M | -$38.18M | -$38.33M | -$138.86M | -$37.93M |
| Non-Operating Interest Expense | $37.28M | $38.18M | $38.33M | $138.86M | $37.93M |
| Other Income (Expense) | -$20.32M | -$27.58M | -$34.54M | -$1.32B | -$1.18B |
| Special Income (Charges) | -$20.32M | -$27.58M | -$34.54M | -$1.32B | -$1.18B |
| -Less:Restructuring and Mergern & Acquisition | $5.47M | $15.11M | $9.59M | $28.37M | $13.23M |
| -Less:Impairment of Capital Assets | $3.55M | – | – | – | – |
| -Less:Other Special Charges | $11.12M | $7.47M | $26.17M | $287.49M | $159.45M |
| -Gain on Sale of Property/Plant/Equipment | -$189,000.00 | $2.36M | $1.22M | $8.72M | $0.00 |
| Pretax Profit | $56.47M | $22.01M | $10.96M | -$1.07B | -$1.17B |
| Tax | $17.82M | $9.75M | $6.50M | $25.98M | $7.84M |
| Net Profit | $38.65M | $12.26M | $4.46M | -$1.09B | -$1.18B |
| Profit from Continuing Operations | $38.65M | $12.26M | $4.46M | -$1.09B | -$1.18B |
| Minority Interests | $4.16M | $1.33M | $359,000.00 | $10.85M | $279,000.00 |
| Net Income to Parent Company | $34.49M | $10.93M | $4.11M | -$1.10B | -$1.18B |
| Net Income to Common Stockholders | $34.49M | $10.93M | $4.11M | -$1.10B | -$1.18B |
| Basic EPS | $0.38 | $0.12 | $0.05 | -$12.16 | -$13.02 |
| Diluted EPS | $0.38 | $0.12 | $0.05 | -$12.16 | -$13.02 |
| -Less:Write Off | – | $7.36M | – | $1.01B | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $5.55B | $5.55B | $5.55B | $5.53B | $5.53B |
| Total Current Assets | $881.32M | $845.29M | $837.20M | $814.14M | $814.14M |
| Cash and Cash Equivalents & Short-Term Investments | $163.31M | $171.29M | $158.47M | $133.24M | $133.24M |
| -Cash and Cash Equivalents | $163.31M | $171.29M | $158.47M | $133.24M | $133.24M |
| Receivables | $561.59M | $555.49M | $547.73M | $545.16M | $545.16M |
| -Accounts Receivable | $501.39M | $470.75M | $471.75M | $440.60M | $440.60M |
| -Taxes Receivable | $39.12M | $49.55M | $46.76M | $41.89M | $41.89M |
| -Other Receivables | $21.08M | $35.19M | $29.22M | $62.67M | $62.67M |
| Prepaid Assets | $73.30M | $54.08M | $56.82M | $65.52M | $65.52M |
| Inventory | $6.25M | $6.26M | $5.93M | $5.69M | $5.69M |
| Other Current Assets | $5.67M | $5.55M | $6.14M | $4.12M | $4.12M |
| Total Non-Current Assets | $4.67B | $4.70B | $4.71B | $4.71B | $4.71B |
| Net PPE | $3.19B | $3.23B | $3.24B | $3.25B | $3.25B |
| -Gross PPE | $4.33B | $4.32B | $4.29B | $4.25B | $4.25B |
| -Accumulated Depreciation | -$1.14B | -$1.09B | -$1.05B | -$1.01B | -$1.01B |
| Goodwill and Other Intangible Assets | $1.42B | $1.40B | $1.40B | $1.39B | $1.39B |
| -Goodwill | $1.32B | $1.30B | $1.30B | $1.30B | $1.30B |
| -Other Intangible Assets | $100.19M | $100.19M | $98.59M | $96.67M | $96.67M |
| Non-Current Deferred Assets | $2.42M | $2.46M | $2.49M | $2.53M | $2.53M |
| Other Non-Current Assets | $67.24M | $66.40M | $67.97M | $72.55M | $72.55M |
| Total Liabilities | $3.30B | $3.35B | $3.38B | $3.39B | $3.39B |
| Total Current Liabilities | $552.03M | $537.58M | $489.36M | $525.19M | $525.19M |
| Payables | $155.34M | $151.92M | $156.05M | $163.93M | $163.93M |
| -Accounts Payable | $138.56M | $135.26M | $142.20M | $150.40M | $150.40M |
| -Total Tax Payable | $16.79M | $16.67M | $13.85M | $13.53M | $13.53M |
| Current Accrued Expenses | $339.15M | $328.13M | $275.74M | $307.77M | $307.77M |
| Short-Term Debt and Capital Lease Obligation | $55.33M | $54.34M | $54.32M | $50.69M | $50.69M |
| -Current Debt | $32.50M | $32.50M | $32.50M | $28.44M | $28.44M |
| -Current Capital Lease Obligation | $22.83M | $21.84M | $21.82M | $22.25M | $22.25M |
| Current Deferred Liabilities | $2.21M | $3.18M | $3.24M | $2.81M | $2.81M |
| Total Non-Current Liabilities | $2.75B | $2.82B | $2.89B | $2.86B | $2.86B |
| Long Term Debt and Capital Lease Obligation | $2.45B | $2.51B | $2.62B | $2.59B | $2.59B |
| -Long Term Debt | $2.32B | $2.38B | $2.49B | $2.47B | $2.47B |
| -Long Term Capital Lease Obligation | $129.55M | $128.85M | $121.36M | $121.96M | $121.96M |
| Non-Current Deferred Liabilities | $93.64M | $87.14M | $76.91M | $66.61M | $66.61M |
| Other Non-Current Liabilities | $207.15M | $218.84M | $196.27M | $201.61M | $201.61M |
| Total Equity | $2.25B | $2.19B | $2.17B | $2.14B | $2.14B |
| Stockholders' Equity | $2.02B | $1.98B | $1.96B | $1.95B | $1.95B |
| Capital Stock | $909,000.00 | $909,000.00 | $908,000.00 | $905,000.00 | $905,000.00 |
| -Common Stock | $909,000.00 | $909,000.00 | $908,000.00 | $905,000.00 | $905,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $2.74B | $2.73B | $2.72B | $2.71B | $2.71B |
| Retained Earnings | -$716.32M | -$750.81M | -$761.74M | -$765.84M | -$765.84M |
| Minority Interests | $229.88M | $212.73M | $209.98M | $191.59M | $191.59M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $97.88M | $162.07M | $61.53M | $131.90M | -$86.29M |
| Net cash flow from continuing operations | $97.88M | $162.07M | $61.53M | $131.90M | -$86.29M |
| Net Income from Continuing Operations | $38.65M | $12.26M | $4.46M | -$1.09B | -$1.18B |
| Gain/Loss from Continuing Operations | $189,000.00 | -$2.36M | -$1.22M | -$7.45M | $0.00 |
| Depreciation & Depletion & Amortization | $53.13M | $50.43M | $52.43M | $189.25M | $45.75M |
| Deferred Tax | $6.54M | $10.26M | $10.34M | $1.09M | -$2.22M |
| Other Non-Cash Items | $1.40M | $1.38M | $1.65M | $9.99M | $1.07M |
| Change in Working Capital | -$14.82M | $71.74M | -$14.09M | -$8.67M | $33.45M |
| -Change in Receivables | -$30.64M | $1.00M | -$31.15M | -$75.02M | -$10.07M |
| -Change in Payables and Accrued Expense | $6.61M | $29.73M | -$10.17M | $41.56M | $2.82M |
| -Change in Other Current Assets | $12.23M | $2.83M | $26.96M | -$58.50M | -$30.05M |
| -Change in Other Current Liabilities | -$3.03M | $38.18M | $270,000.00 | $83.30M | $70.74M |
| Net cash flow from investing | -$42.51M | -$32.68M | -$60.21M | -$556.21M | -$92.44M |
| Net Cash Flow from Continuing Investing Activities | -$42.51M | -$32.68M | -$60.21M | -$556.21M | -$92.44M |
| Capital Expenditure | -$50.74M | -$38.55M | -$76.56M | -$571.81M | -$93.19M |
| Net PPE Purchase and Sale | $7.40M | $10.11M | $16.38M | $23.85M | $697,000.00 |
| Net Business Purchase and Sale | $0.00 | $0.00 | $0.00 | -$8.17M | $0.00 |
| Net Other Investing Changes | $831,000.00 | -$4.24M | -$30,000.00 | -$90,000.00 | $55,000.00 |
| Financing Cash Flow | -$63.36M | -$116.57M | $23.91M | $481.25M | $193.28M |
| Net Cash Flow from Continuing Financing Activities | -$63.36M | -$116.57M | $23.91M | $481.25M | $193.28M |
| Net Issuance Payments Of Debt | -$63.13M | -$113.13M | $25.94M | $550.96M | $189.94M |
| Net Common Stock Issuance | $0.00 | $0.00 | $0.00 | -$50.03M | $0.00 |
| Net Other Financing Charges | -$233,000.00 | -$3.45M | -$2.03M | -$19.67M | $3.34M |
| Ending Cash Balance | $163.31M | $171.29M | $158.47M | $133.24M | $133.24M |
| Net Change in Cash | -$7.98M | $12.82M | $25.23M | $56.94M | $14.55M |
| Beginning Cash Balance | $171.29M | $158.47M | $133.24M | $76.31M | $118.69M |
| Free Cash Flow | $47.14M | $123.51M | -$15.03M | -$439.91M | -$179.48M |
No comments yet — be the first to weigh in on ACHC.
Sign in to join the discussion.